Analyst firms · Jefferies · TYRA

Jefferies TYRA price target and rating history

Tyra Biosciences Inc. (TYRA) · Health Care

Jefferies rates Tyra Biosciences Inc. (TYRA) Buy with a $27 price target, as of its latest action on Mar 8, 2022. It has published 4 rating actions on TYRA since October 2021, including 1 upgrade and 2 downgrades. Across 3 firms with a TYRA price target in the last 12 months, the median target is $54.

Current rating

Buy

Price target

$27

Median target, all firms

$54

Actions on TYRA

4

Jefferies price target on TYRA

Every Jefferies rating on TYRA

• Mar 8, 2022
  UpgradeJefferies upgrades to Buy from Hold, price target $31 to $27
• Nov 8, 2021
  DowngradeJefferies downgrades to Hold from Buy, price target $19 to $31
• Nov 8, 2021
  DowngradeJefferies downgrades to Hold from Buy
• Oct 11, 2021
  InitiateJefferies starts coverage at Buy, price target $19

How other firms rate TYRA

Each firm's latest rating and stated target in the last 12 months.

Questions about Jefferies and TYRA

What is Jefferies's price target for TYRA?

Jefferies's latest stated price target for Tyra Biosciences Inc. (TYRA) is $27, from its action on Mar 8, 2022.

What is Jefferies's rating on TYRA?

Jefferies rates TYRA Buy, a bullish rating, as of Mar 8, 2022.

When did Jefferies last change its view on TYRA?

On Mar 8, 2022, Jefferies upgrades to Buy from Hold, price target $31 to $27.

How does Jefferies's TYRA target compare with other analysts?

Across 3 firms with a TYRA price target in the last 12 months, the median target is $54.

More TYRA rating histories

• BofA Securities3

All Jefferies ratingsTYRA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.